Abstract
Summary
The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the diagnosis and management of the full spectrum of Stevens–Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and SJS-TEN overlap in adults during the acute phase of the disease. The document aims to:∗ offer an appraisal of all relevant literature up to February 2016, focusing on any key developments. ∗ address important, practical clinical questions relating to the primary guideline objective, i.e. accurate diagnosis and identification of cases and suitable treatment. ∗ provide guideline recommendations. ∗ discuss areas of uncertainty, potential developments and future directions.
The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the diagnosis and management of the full spectrum of Stevens–Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and SJS-TEN overlap in adults during the acute phase of the disease. The document aims to:∗ offer an appraisal of all relevant literature up to February 2016, focusing on any key developments. ∗ address important, practical clinical questions relating to the primary guideline objective, i.e. accurate diagnosis and identification of cases and suitable treatment. ∗ provide guideline recommendations. ∗ discuss areas of uncertainty, potential developments and future directions.
Original language | English |
---|---|
Pages (from-to) | e119–e153 |
Journal | Journal of Plastic Reconstructive and Aesthetic Surgery |
Volume | 69 |
Issue number | 6 |
Early online date | 7 May 2016 |
DOIs | |
Publication status | Published - Jun 2016 |
Keywords
- Stevens-Johnson syndrome
- toxic epidermal necrolysis
- drug hypersensitivity
- management
- guidelines